cordycepin has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Bi, Y; Chen, Y; Li, H; Liu, Q; Yi, D; Zhao, G; Zhong, S | 1 |
| Chen, Y; Hueng, DY; Liao, CC; Syu, JP; Wu, YC; Yang, SH | 1 |
2 other study(ies) available for cordycepin and Glioma
| Article | Year |
|---|---|
β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Cell Line, Tumor; Cell Survival; Deoxyadenosines; Drug Resistance, Neoplasm; Glioma; Humans; Kaplan-Meier Estimate; Male; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; O(6)-Methylguanine-DNA Methyltransferase; Rats, Wistar; Reactive Oxygen Species; Temozolomide; Xenograft Model Antitumor Assays | 2018 |
Cordycepin induces apoptosis of C6 glioma cells through the adenosine 2A receptor-p53-caspase-7-PARP pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 7; Cell Line, Tumor; Cell Survival; Deoxyadenosines; Gene Expression Regulation, Neoplastic; Glioma; Poly(ADP-ribose) Polymerases; Rats; Receptors, Adenosine A2; RNA Interference; RNA, Small Interfering; Tumor Suppressor Protein p53 | 2014 |